Reckitt Benckiser Group (LON:RKT – Get Rating)‘s stock had its “outperform” rating reaffirmed by investment analysts at Royal Bank of Canada in a report released on Wednesday, Digital Look reports. They currently have a GBX 7,000 ($88.56) target price on the stock. Royal Bank of Canada’s target price indicates a potential upside of 11.54% from the stock’s previous close.
RKT has been the subject of a number of other research reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 7,200 ($91.09) price target on shares of Reckitt Benckiser Group in a report on Thursday, May 26th. Morgan Stanley restated an “overweight” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, May 11th. Berenberg Bank increased their price target on Reckitt Benckiser Group from GBX 7,460 ($94.38) to GBX 7,700 ($97.42) and gave the stock a “buy” rating in a report on Friday, April 29th. JPMorgan Chase & Co. reissued an “overweight” rating on shares of Reckitt Benckiser Group in a research report on Thursday, May 12th. Finally, Barclays reaffirmed an “overweight” rating and issued a GBX 9,300 ($117.66) target price on shares of Reckitt Benckiser Group in a research report on Friday, May 20th. Nine research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Reckitt Benckiser Group currently has a consensus rating of “Buy” and an average target price of GBX 7,677.78 ($97.14).
Shares of RKT opened at GBX 6,276 ($79.40) on Wednesday. Reckitt Benckiser Group has a 12-month low of GBX 4,905.16 ($62.06) and a 12-month high of GBX 6,709 ($84.88). The firm has a market capitalization of £44.86 billion and a P/E ratio of -1,394.22. The firm has a 50-day moving average price of GBX 6,099.97 and a 200 day moving average price of GBX 6,115.08. The company has a current ratio of 0.62, a quick ratio of 0.40 and a debt-to-equity ratio of 129.26.
About Reckitt Benckiser Group (Get Rating)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
- American Well Corporation Stock May Well Be Bottoming
- 3 Outperforming Energy Stocks with More in the Tank
- There Are Cracks In The Paint At Sherwin-Williams
- Three Beaten Down Stocks The Insiders Are Buying
- Should Medtronic Make the Cut For Your Recovery Watchlist?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.